The company trades agricultural commodities and chemical products, primarily operating as a middleman in the Indian domestic market.
The company operates in a highly fragmented commodity trading space with no evidence of brand power, cost advantages, or proprietary technology. Returns on capital are consistently near zero, and net margins are volatile, confirming the lack of any competitive barrier.
Capital has been deployed into low-yielding loans and advances rather than productive assets. A significant portion of the balance sheet is tied up in 'Long Term Loans and Advances' and 'Capital Work in Progress' that have remained stagnant for years without generating returns.
The company's collapse was precipitated by the 'Long Term Loans and Advances' being revealed as unrecoverable gifts to related parties rather than productive assets. As the stagnant 'Capital Work in Progress' was eventually written off as a total loss, the already eroded net worth vanished completely. The lack of a CFO and the revolving door of auditors masked a terminal liquidity crisis until the exchange finally suspended the stock for persistent regulatory non-compliance and failure to publish financial results.
RichFakir rates Natural Biocon (India) Ltd's business quality as poor — 30/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Natural Biocon (India) Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Natural Biocon (India) Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Natural Biocon (India) Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →